FY2017 Earnings Forecast for UnitedHealth Group Incorporated (UNH) Issued By Jefferies Group
UnitedHealth Group Incorporated (NYSE:UNH) – Investment analysts at Jefferies Group upped their FY2017 earnings per share estimates for UnitedHealth Group in a research report issued on Tuesday. Jefferies Group analyst D. Windley now expects that the healthcare conglomerate will post earnings of $10.00 per share for the year, up from their previous estimate of $9.88. Jefferies Group has a “Buy” rating and a $225.00 price objective on the stock. Jefferies Group also issued estimates for UnitedHealth Group’s Q4 2017 earnings at $2.51 EPS, Q1 2018 earnings at $2.68 EPS, Q2 2018 earnings at $2.67 EPS, Q3 2018 earnings at $2.88 EPS, Q4 2018 earnings at $2.63 EPS, FY2018 earnings at $10.86 EPS and FY2019 earnings at $12.42 EPS.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the business earned $2.17 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/19/fy2017-earnings-forecast-for-unitedhealth-group-incorporated-unh-issued-by-jefferies-group.html.
Other research analysts have also issued research reports about the stock. Citigroup Inc. lifted their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Cantor Fitzgerald reissued a “buy” rating and set a $205.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 7th. Stifel Nicolaus reissued a “buy” rating and set a $185.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 28th. BidaskClub lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, Mizuho set a $235.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, July 18th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $212.40.
Shares of UnitedHealth Group (UNH) opened at 205.23 on Thursday. The stock’s 50 day moving average is $196.96 and its 200-day moving average is $185.50. The firm has a market cap of $198.43 billion, a price-to-earnings ratio of 24.66 and a beta of 0.63. UnitedHealth Group has a 12-month low of $133.03 and a 12-month high of $207.80.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock worth $14,981,909 over the last quarter. 0.89% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Osborn Williams & Donohoe LLC raised its holdings in shares of UnitedHealth Group by 6.1% in the third quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock valued at $2,743,000 after purchasing an additional 810 shares during the last quarter. Curbstone Financial Management Corp raised its holdings in shares of UnitedHealth Group by 74.7% in the third quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock valued at $744,000 after purchasing an additional 1,625 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $1,254,000. Intl Fcstone Inc. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $2,324,000. Finally, RNC Capital Management LLC raised its holdings in shares of UnitedHealth Group by 0.7% in the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the last quarter. Institutional investors own 86.11% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.